C1q Antibody (Polyclonal)
A goat antiserum raised against human C1q protein
Product Specifications
Citations | 14 |
---|---|
Clonality | Polyclonal |
Immnogen | Highly purified human human C1q protein |
Applications | See citations and technical data sheet for application info. |
Concentration | > 40 mg/mL |
Conjugate | Unconjugated |
Cross Reactivity | Human, Baboon, Horse, Dog, Cat, Rabbit, Hamster, Mouse, Rat, Guinea Pig |
Ordering Information
Catalog Number | A301 |
---|---|
Catalog Number (CE) | N/A |
Size | 2.0 mL |
Price (USD) | $235.00 |
Price (EURO) | 205,00 € |
Contact us
US Phone | +1 (858) 552 1100 |
---|---|
EU Phone | +353 (91) 412 474 |
US Email | contact-us@quidelortho.com |
EU Email | contact-emea@quidelortho.com |
- Specifications
- Citations
- Certificate of Analysis
Specifications
Description | A goat antiserum raised against human C1q protein |
---|---|
Size | 2.0 mL |
Concentration | > 40 mg/mL |
Applications | See citations and technical data sheet for application info. |
Form | Liquid. Whole Antiserum. ≤ 0.1% Sodium Azide |
Clonality | Polyclonal |
Immunogen | Highly purified human human C1q protein |
Conjugate | Unconjugated |
Cross Reactivity | Human, Baboon, Horse, Dog, Cat, Rabbit, Hamster, Mouse, Rat, Guinea Pig |
Isotype | Goat IgG |
Purity | N/A |
Source | Goat |
Specificity | The Anti-human C1q was tested against normal human plasma by double immunodiffusion, one-dimensional immunoelectrophoresis, two-dimensional immunoelectrophoresis, and quantitative rocket immunoelectrophoresis. The antiserum was determined to be monospecific for C1q at varying concentrations. |
Storage | Short term (30 days) 4˚C. Long term at or below –20˚C. |
Background | The C1q molecule is a large protein with a molecular weight of 410 kD. This hexamer is composed of three unique protein subunits (A, B, and C) with molecular weights of 29, 26, and 22 kD respectively, and is present in normal human serum at an approximate concentration of 70 µg/mL. The assembled C1q molecule contains a central core or stalk, six collagen-like domains and six globular protein heads, resulting in a the appearance of a “bouquet of tulips.” The globular or terminal regions are responsible for binding the Fc portion of immunoglobulin (IgM, and IgG). C1q is one of three subcomponents that together make the first component of the classical complement pathway, C1. C1q complexes with two C1s and two C1r components, and together, they form the C1 complex. Initiation of the classical complement pathway occurs when C1q binds with IgM or IgG containing antigen-antibody complexes. |
Citations
Title | Year | Applications | Sample Species | Sample | Sample Details |
---|---|---|---|---|---|
2022 | ELISA | Human | Serum | N/A | |
2021 | ELISA | Human | Eye Tissue | Age-Related Macular Degeneration | |
The Surface-Exposed Protein SntA Contributes to Complement Evasion in Zoonotic Streptococcus suis | 2018 | ELISA | Human | Purified protein | N/A |
Serologic features of cohorts with variable genetic risk for systemic lupus erythematosus | 2018 | ELISA | Human | Serum | Systemic Lupus Erythematosus |
Neurotoxic reactive astrocytes are induced by activated microglia | 2017 | Neutralization | Rat | Protein Injection | N/A |
Broad Susceptibility of Nucleolar Proteins and Autoantigens to Complement C1 Protease Degradation. | 2017 | WB | Human | HeLa Cells | N/A |
2016 | ELISA | N/A | IVIg | Exposed to ferrous ions | |
2016 | WB | Cell Culture | Jurkat Cells | N/A | |
2015 | IP | Mouse | Brain Tissue | Cerebellum myelin substrate | |
Inhibition of aberrant complement activation by a dimer of acetylsalicylic acid. | 2015 | WB | Human | Serum | Acetyl salicylic acid dimer 5,5'-methylenebis(2-acetoxybenzoic acid) (DAS) |
2012 | ELISA, IF, WB | Human | Dendritic Cell | N/A | |
2010 | ELISA | N/A | CD44 (coating) | N/A | |
Early Involvement of Immune/Inflammatory Response Genes in Retinal Degeneration in DBA/2J Mice | 2010 | IF | Mouse | Microglial Cells | N/A |
2006 | WB | Human | Serum | Moraxella catarrhalis |